Albireo Pharma Inc (ALBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2012 | 06-2012 | 03-2012 | 12-2011 | 09-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -14,868 | -8,818 | -4,501 | N/A |
| Depreciation Amortization | N/A | 555 | 382 | 194 | N/A |
| Accounts receivable | N/A | 1 | 1 | 1 | N/A |
| Accounts payable and accrued liabilities | N/A | -42 | -108 | -71 | N/A |
| Other Working Capital | N/A | 152 | -114 | -349 | N/A |
| Other Operating Activity | 0 | 2,944 | 1,285 | 1,057 | 0 |
| Operating Cash Flow | $N/A | $-11,258 | $-7,372 | $-3,669 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -6 | N/A | N/A |
| Investing Cash Flow | $N/A | $N/A | $-6 | $0 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 8,730 | 21 | N/A | N/A |
| Common Stock Repurchased | N/A | 27 | N/A | 20 | N/A |
| Other Financing Activity | 0 | 7,491 | -1,500 | 0 | 0 |
| Financing Cash Flow | $N/A | $16,248 | $-1,479 | $20 | $N/A |
| Beginning Cash Position | N/A | 38,701 | 38,701 | 38,701 | N/A |
| End Cash Position | N/A | 43,691 | 29,844 | 35,052 | N/A |
| Net Cash Flow | $N/A | $4,990 | $-8,857 | $-3,649 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | -11,258 | -7,372 | -3,669 | N/A |
| Capital Expenditure | N/A | N/A | -6 | 0 | N/A |
| Free Cash Flow | 0 | -11,258 | -7,378 | -3,669 | 0 |